This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2010 Remove Budgeting Remove Ethics Remove Health Care
article thumbnail

Big Pharma's Hidden Business Model and How Your Company Funds It

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. See The Risks of Prescription Drugs (Columbia 2010).

Business Model 15
Business Model Company Pharmaceuticals Price 15
article thumbnail

How the New U.S. Tax Plan Will Affect Health Care

Harvard Business Review

DECEMBER 19, 2017

It will mean less health insurance for individuals; less coverage for elderly and poor Americans; less revenue for doctors, hospitals, and myriad health care businesses; and, quite possibly, a less-healthy, less-productive workforce. Many will also lose health insurance. Precipitous cuts, however, could be damaging.

Health Care 8
Health Care Planning Insurance Budgeting 8
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 5,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024